Evidence map›Paper›PMID 42441093›Full record

ArticleEuropean heart journal. Case reports2026

Sudden cardiac death in a child with low-risk hypertrophic cardiomyopathy: limitations of current pediatric risk stratification-a case report.

Salma Bensalah, Amina Outahayou, Abdellah Sbai Sassi, Ibtissam Fellat, Mohamed Cherti

Abstract readCase Reports
In one paragraph

Article in European heart journal. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Salma BensalahDepartment of Cardiology B, CHU IBN Sina, Rabat 12000, Morocco.ORCID https://orcid.org/0009-0001-1260-7841
Amina OutahayouDepartment of Cardiology B, CHU IBN Sina, Rabat 12000, Morocco.
Abdellah Sbai SassiDepartment of Cardiology B, CHU IBN Sina, Rabat 12000, Morocco.ORCID https://orcid.org/0009-0003-0609-1409
Ibtissam FellatDepartment of Cardiology B, CHU IBN Sina, Rabat 12000, Morocco.ORCID https://orcid.org/0009-0004-4967-3465
Mohamed ChertiDepartment of Cardiology B, CHU IBN Sina, Rabat 12000, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hypertrophic cardiomyopathy (HCM) is characterized by marked phenotypic heterogeneity and remains a leading cause of sudden cardiac death (SCD) in young individuals. Risk stratification in children is particularly challenging, and current predictive models may underestimate arrhythmic risk in certain patients. Case summary: We report a familial case of sarcomeric HCM. A 41-year-old man presented with sustained ventricular tachycardia revealing asymmetric HCM, requiring implantable cardioverter-defibrillator (ICD) implantation, and later died from end-stage heart failure. His 12-year-old son was diagnosed with asymmetric HCM and was classified as low risk according to the HCM Risk-Kids score. At the time of evaluation, the child did not meet current guideline based criteria for ICD implantation. Nevertheless, SCD occurred during moderate physical exertion 2 months after diagnosis. Discussion: This familial case highlights the limitations of paediatric risk stratification scores at the individual level and underscores the need for a more individualized approach integrating family history, early phenotypic expression, advanced imaging findings, and genetic context beyond risk scores alone.

Indexed as

Case reportHypertrophic cardiomyopathyImplantable cardioverter–defibrillatorRisk stratificationSudden cardiac death

Identifiers

PMID42441093
PMCPMC13335802

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.